Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Alpha 1-antitrypsin expression in human thyroid papillary carcinoma.

Poblete MT, Nualart F, del Pozo M, Perez JA, Figueroa CD.

Am J Surg Pathol. 1996 Aug;20(8):956-63.

PMID:
8712295
2.

Alpha-1-antichymotrypsin immunoreactivity in papillary carcinoma of the thyroid gland.

Lai ML, Rizzo N, Liguori C, Zucca G, Faa G.

Histopathology. 1998 Oct;33(4):332-6.

PMID:
9822922
4.

Intranodal benign thyroid tissue: significance of HBME-1 in differentiation from metastatic papillary thyroid carcinoma.

Hirokawa M, Horiguchi H, Wakatsuki S, Miki H, Sonoo H, Manabe T, Sano T.

APMIS. 2001 Dec;109(12):875-80.

PMID:
11846730
5.

Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.

Wenig BM, Thompson LD, Adair CF, Shmookler B, Heffess CS.

Cancer. 1998 Feb 15;82(4):740-53.

PMID:
9477108
6.
7.

MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid.

Bièche I, Ruffet E, Zweibaum A, Vildé F, Lidereau R, Franc B.

Thyroid. 1997 Oct;7(5):725-31.

PMID:
9349575
8.

Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas.

Fellmer PT, Sato K, Tanaka R, Okamoto T, Kato Y, Kobayashi M, Shibuya M, Obara T.

Surgery. 1999 Dec;126(6):1056-61; discussion 1061-2.

PMID:
10598188
9.

Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.

Pesutić-Pisac V, Punda A, Gluncić I, Bedeković V, Pranić-Kragić A, Kunac N.

Croat Med J. 2008 Oct;49(5):643-9.

10.

A metastasizing composite carcinoma of the thyroid with distinct medullary and papillary components.

Apel RL, Alpert LC, Rizzo A, LiVolsi VA, Asa SL.

Arch Pathol Lab Med. 1994 Nov;118(11):1143-7.

PMID:
7979902
11.

Galectin-3 is a presurgical marker of human thyroid carcinoma.

Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, De Giuli P, Angeli A.

Cancer Res. 1998 Jul 15;58(14):3015-20.

12.

A novel tumor marker, Niban, is expressed in subsets of thyroid tumors and Hashimoto's thyroiditis.

Matsumoto F, Fujii H, Abe M, Kajino K, Kobayashi T, Matsumoto T, Ikeda K, Hino O.

Hum Pathol. 2006 Dec;37(12):1592-600. Epub 2006 Sep 1.

PMID:
16949643
14.

EGF-receptors in human normal and pathological thyroid tissue.

Westermark K, Lundqvist M, Wallin G, Dahlman T, Hacker GW, Heldin NE, Grimelius L.

Histopathology. 1996 Mar;28(3):221-7.

PMID:
8729040
15.

Papillary carcinoma of the thyroid with mucoepidermoid differentiation.

Viciana MJ, Galera-Davidson H, Martín-Lacave I, Segura DI, Loizaga JM.

Arch Pathol Lab Med. 1996 Apr;120(4):397-8.

PMID:
8619755
16.
17.

Reduced expression of retinoic acid receptor beta protein (RAR beta) in human papillary thyroid carcinoma: immunohistochemical and western blot study.

Rochaix P, Monteil-Onteniente S, Rochette-Egly C, Caratero C, Voigt JJ, Jozan S.

Histopathology. 1998 Oct;33(4):337-43.

PMID:
9822923
18.

Mixed medullary-papillary carcinoma of the thyroid: a previously unrecognized variant of thyroid carcinoma.

Albores-Saavedra J, Gorraez de la Mora T, de la Torre-Rendon F, Gould E.

Hum Pathol. 1990 Nov;21(11):1151-5.

PMID:
2227923
19.

Follicular adenoma with papillary architecture: a lesion mimicking papillary thyroid carcinoma.

Mai KT, Landry DC, Thomas J, Burns BF, Commons AS, Yazdi HM, Odell PF.

Histopathology. 2001 Jul;39(1):25-32.

PMID:
11454041
20.

Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.

Xu X, Quiros RM, Maxhimer JB, Jiang P, Marcinek R, Ain KB, Platt JL, Shen J, Gattuso P, Prinz RA.

Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5968-79.

Supplemental Content

Support Center